1. Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. 2. Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China. 3. Department of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. 4. Department of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. 5. Department of Urology, The First Affiliated Hospital of Xiamen University, Xiamen, China. *These authors contributed equally to this work.
✉ Corresponding author: Prof. Hua Xu, Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. E-mail: xuhuaedu.cn.
Citation:
Liu H, Yang X, Tang K, Ye T, Duan C, Lv P, Yan L, Wu X, Chen Z, Liu J, Deng Y, Zeng G, Xing J, Ye Z, Xu H. Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum. Theranostics 2022; 12(1):421. doi:10.7150/thno.68830. https://www.thno.org/v12p0421.htm
Liu, H., Yang, X., Tang, K., Ye, T., Duan, C., Lv, P., Yan, L., Wu, X., Chen, Z., Liu, J., Deng, Y., Zeng, G., Xing, J., Ye, Z., Xu, H. (2022). Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum. Theranostics, 12(1), 421. https://doi.org/10.7150/thno.68830.
ACS
Liu, H.; Yang, X.; Tang, K.; Ye, T.; Duan, C.; Lv, P.; Yan, L.; Wu, X.; Chen, Z.; Liu, J.; Deng, Y.; Zeng, G.; Xing, J.; Ye, Z.; Xu, H. Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum. Theranostics 2022, 12 (1), 421. DOI: 10.7150/thno.68830.
NLM
Liu H, Yang X, Tang K, Ye T, Duan C, Lv P, Yan L, Wu X, Chen Z, Liu J, Deng Y, Zeng G, Xing J, Ye Z, Xu H. Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum. Theranostics 2022; 12(1):421. doi:10.7150/thno.68830. https://www.thno.org/v12p0421.htm
CSE
Liu H, Yang X, Tang K, Ye T, Duan C, Lv P, Yan L, Wu X, Chen Z, Liu J, Deng Y, Zeng G, Xing J, Ye Z, Xu H. 2022. Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum. Theranostics. 12(1):421.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.